Altimmune (STU:3G0) EV-to-Revenue : 899.95 (As of May. 15, 2024)

Altimmune EV-to-Revenue Chart

Altimmune Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue		Get a 7-Day Free Trial					-1.13	25.03	42.34	-9,199.72	1,403.70

Altimmune Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-547.80	-331.24	-9.17	1,403.70	-

Competitive Comparison of Altimmune's EV-to-Revenue

For the Biotechnology subindustry, Altimmune's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altimmune's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altimmune's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Altimmune's EV-to-Revenue falls into.

Altimmune EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Altimmune's EV-to-Revenue for today is calculated as:

Altimmune's current Enterprise Value is €345.58 Mil.
Altimmune's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altimmune  (STU:3G0) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Altimmune's PS Ratiofor today is calculated as:

Altimmune's share price for today is €7.162.
Altimmune's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Altimmune EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Altimmune's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Altimmune (STU:3G0) Business Description